<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37395272</PMID><DateCompleted><Year>2023</Year><Month>07</Month><Day>04</Day></DateCompleted><DateRevised><Year>2023</Year><Month>07</Month><Day>05</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1558-8238</ISSN><JournalIssue CitedMedium="Internet"><Volume>133</Volume><Issue>13</Issue><PubDate><Year>2023</Year><Month>Jul</Month><Day>03</Day></PubDate></JournalIssue><Title>The Journal of clinical investigation</Title><ISOAbbreviation>J Clin Invest</ISOAbbreviation></Journal><ArticleTitle>Disrupting pathologic phase transitions in neurodegeneration.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">e168549</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1172/JCI168549</ELocationID><Abstract><AbstractText>Solid-like protein deposits found in aged and diseased human brains have revealed a relationship between insoluble protein accumulations and the resulting deficits in neurologic function. Clinically diverse neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, frontotemporal lobar degeneration, and amyotrophic lateral sclerosis, exhibit unique and disease-specific biochemical protein signatures and abnormal protein depositions that often correlate with disease pathogenesis. Recent evidence indicates that many pathologic proteins assemble into liquid-like protein phases through the highly coordinated process of liquid-liquid phase separation. Over the last decade, biomolecular phase transitions have emerged as a fundamental mechanism of cellular organization. Liquid-like condensates organize functionally related biomolecules within the cell, and many neuropathology-associated proteins reside within these dynamic structures. Thus, examining biomolecular phase transitions enhances our understanding of the molecular mechanisms mediating toxicity across diverse neurodegenerative diseases. This Review explores the known mechanisms contributing to aberrant protein phase transitions in neurodegenerative diseases, focusing on tau and TDP-43 proteinopathies and outlining potential therapeutic strategies to regulate these pathologic events.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hurtle</LastName><ForeName>Bryan T</ForeName><Initials>BT</Initials><AffiliationInfo><Affiliation>Center for Neuroscience at the University of Pittsburgh Graduate Program.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Medical Scientist Training Program, University of Pittsburgh; and.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>LiveLikeLou Center for ALS Research at the University of Pittsburgh Brain Institute; Pittsburgh, Pennsylvania, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurobiology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xie</LastName><ForeName>Longxin</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>LiveLikeLou Center for ALS Research at the University of Pittsburgh Brain Institute; Pittsburgh, Pennsylvania, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurobiology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Medicine, Tsinghua University, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Donnelly</LastName><ForeName>Christopher J</ForeName><Initials>CJ</Initials><AffiliationInfo><Affiliation>Center for Neuroscience at the University of Pittsburgh Graduate Program.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Medical Scientist Training Program, University of Pittsburgh; and.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>LiveLikeLou Center for ALS Research at the University of Pittsburgh Brain Institute; Pittsburgh, Pennsylvania, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurobiology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 NS127187</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>L30 AG048607</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 NS105756</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>07</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Clin Invest</MedlineTA><NlmUniqueID>7802877</NlmUniqueID><ISSNLinking>0021-9738</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011506">Proteins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057177" MajorTopicYN="Y">TDP-43 Proteinopathies</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019636" MajorTopicYN="Y">Neurodegenerative Diseases</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057174" MajorTopicYN="Y">Frontotemporal Lobar Degeneration</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011506" MajorTopicYN="N">Proteins</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>7</Month><Day>4</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>7</Month><Day>3</Day><Hour>13</Hour><Minute>5</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>7</Month><Day>3</Day><Hour>6</Hour><Minute>34</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37395272</ArticleId><ArticleId IdType="pmc">PMC10313377</ArticleId><ArticleId IdType="doi">10.1172/JCI168549</ArticleId><ArticleId IdType="pii">168549</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Fu H, et al. Selective vulnerability in neurodegenerative diseases. Nat Neurosci. 2018;21(10):1350&#x2013;1358. doi: 10.1038/s41593-018-0221-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-018-0221-2</ArticleId><ArticleId IdType="pmc">PMC6360529</ArticleId><ArticleId IdType="pubmed">30250262</ArticleId></ArticleIdList></Reference><Reference><Citation>Elahi FM, Miller BL. A clinicopathological approach to the diagnosis of dementia. Nat Rev Neurol. 2017;13(8):457&#x2013;476. doi: 10.1038/nrneurol.2017.96.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2017.96</ArticleId><ArticleId IdType="pmc">PMC5771416</ArticleId><ArticleId IdType="pubmed">28708131</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilson DM, et al. Hallmarks of neurodegenerative diseases. Cell. 2023;186(4):693&#x2013;714. doi: 10.1016/j.cell.2022.12.032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2022.12.032</ArticleId><ArticleId IdType="pubmed">36803602</ArticleId></ArticleIdList></Reference><Reference><Citation>Eisenberg D, Jucker M. The amyloid state of proteins in human diseases. Cell. 2012;148(6):1188&#x2013;1203. doi: 10.1016/j.cell.2012.02.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2012.02.022</ArticleId><ArticleId IdType="pmc">PMC3353745</ArticleId><ArticleId IdType="pubmed">22424229</ArticleId></ArticleIdList></Reference><Reference><Citation>Soto C, Pritzkow S. Protein misfolding, aggregation, and conformational strains in neurodegenerative diseases. Nat Neurosci. 2018;21(10):1332&#x2013;1340. doi: 10.1038/s41593-018-0235-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-018-0235-9</ArticleId><ArticleId IdType="pmc">PMC6432913</ArticleId><ArticleId IdType="pubmed">30250260</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellenguez C, et al. New insights into the genetic etiology of Alzheimer&#x2019;s disease and related dementias. Nat Genet. 2022;54(4):412&#x2013;436. doi: 10.1038/s41588-022-01024-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41588-022-01024-z</ArticleId><ArticleId IdType="pmc">PMC9005347</ArticleId><ArticleId IdType="pubmed">35379992</ArticleId></ArticleIdList></Reference><Reference><Citation>Gan L, et al. Converging pathways in neurodegeneration, from genetics to mechanisms. Nat Neurosci. 2018;21(10):1300&#x2013;1309. doi: 10.1038/s41593-018-0237-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-018-0237-7</ArticleId><ArticleId IdType="pmc">PMC6278826</ArticleId><ArticleId IdType="pubmed">30258237</ArticleId></ArticleIdList></Reference><Reference><Citation>Karch CM, et al. Selective genetic overlap between amyotrophic lateral sclerosis and diseases of the frontotemporal dementia spectrum. JAMA Neurol. 2018;75(7):860&#x2013;875. doi: 10.1001/jamaneurol.2018.0372.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2018.0372</ArticleId><ArticleId IdType="pmc">PMC6043387</ArticleId><ArticleId IdType="pubmed">29630712</ArticleId></ArticleIdList></Reference><Reference><Citation>Arvanitakis Z, et al. Diagnosis and management of dementia: review. JAMA. 2019;322(16):1589&#x2013;1599. doi: 10.1001/jama.2019.4782.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2019.4782</ArticleId><ArticleId IdType="pmc">PMC7462122</ArticleId><ArticleId IdType="pubmed">31638686</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, Mandelkow E. Tau in physiology and pathology. Nat Rev Neurosci. 2016;17(1):5&#x2013;21. doi: 10.1038/nrn.2015.1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrn.2015.1</ArticleId><ArticleId IdType="pubmed">26631930</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang CW, et al. Tau: enabler of diverse brain disorders and target of rapidly evolving therapeutic strategies. Science. 2021;371(6532):eabb8255. doi: 10.1126/science.abb8255.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abb8255</ArticleId><ArticleId IdType="pmc">PMC8118650</ArticleId><ArticleId IdType="pubmed">33632820</ArticleId></ArticleIdList></Reference><Reference><Citation>Portz B, et al. FUS and TDP-43 phases in health and disease. Trends Biochem Sci. 2021;46(7):550&#x2013;563. doi: 10.1016/j.tibs.2020.12.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tibs.2020.12.005</ArticleId><ArticleId IdType="pmc">PMC8195841</ArticleId><ArticleId IdType="pubmed">33446423</ArticleId></ArticleIdList></Reference><Reference><Citation>Zbinden A, et al. Phase separation and neurodegenerative diseases: a disturbance in the force. Dev Cell. 2020;55(1):45&#x2013;68. doi: 10.1016/j.devcel.2020.09.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.devcel.2020.09.014</ArticleId><ArticleId IdType="pubmed">33049211</ArticleId></ArticleIdList></Reference><Reference><Citation>Nelson PT, et al. Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report. Brain. 2019;142(6):1503&#x2013;1527. doi: 10.1093/brain/awz099.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awz099</ArticleId><ArticleId IdType="pmc">PMC6536849</ArticleId><ArticleId IdType="pubmed">31039256</ArticleId></ArticleIdList></Reference><Reference><Citation>Chornenkyy Y, et al. Tau and TDP-43 proteinopathies: kindred pathologic cascades and genetic pleiotropy. Lab Invest. 2019;99(7):993&#x2013;1007. doi: 10.1038/s41374-019-0196-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41374-019-0196-y</ArticleId><ArticleId IdType="pmc">PMC6609463</ArticleId><ArticleId IdType="pubmed">30742063</ArticleId></ArticleIdList></Reference><Reference><Citation>Ling SC, et al. Converging mechanisms in ALS and FTD: disrupted RNA and protein homeostasis. Neuron. 2013;79(3):416&#x2013;438. doi: 10.1016/j.neuron.2013.07.033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2013.07.033</ArticleId><ArticleId IdType="pmc">PMC4411085</ArticleId><ArticleId IdType="pubmed">23931993</ArticleId></ArticleIdList></Reference><Reference><Citation>Chung DEC, et al. Cellular and pathological heterogeneity of primary tauopathies. Mol Neurodegener. 2021;16(1):57. doi: 10.1186/s13024-021-00476-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-021-00476-x</ArticleId><ArticleId IdType="pmc">PMC8381569</ArticleId><ArticleId IdType="pubmed">34425874</ArticleId></ArticleIdList></Reference><Reference><Citation>McKee AC, et al. TDP-43 proteinopathy and motor neuron disease in chronic traumatic encephalopathy. J Neuropathol Exp Neurol. 2010;69(9):918&#x2013;929. doi: 10.1097/NEN.0b013e3181ee7d85.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/NEN.0b013e3181ee7d85</ArticleId><ArticleId IdType="pmc">PMC2951281</ArticleId><ArticleId IdType="pubmed">20720505</ArticleId></ArticleIdList></Reference><Reference><Citation>Tremblay C, et al. Accumulation of transactive response DNA binding protein 43 in mild cognitive impairment and Alzheimer disease. J Neuropathol Exp Neurol. 2011;70(9):788&#x2013;798. doi: 10.1097/NEN.0b013e31822c62cf.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/NEN.0b013e31822c62cf</ArticleId><ArticleId IdType="pmc">PMC3197017</ArticleId><ArticleId IdType="pubmed">21865887</ArticleId></ArticleIdList></Reference><Reference><Citation>Wegmann S, et al. Tau protein liquid-liquid phase separation can initiate tau aggregation. EMBO J. 2018;37(7):e98049. doi: 10.15252/embj.201798049.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.201798049</ArticleId><ArticleId IdType="pmc">PMC5881631</ArticleId><ArticleId IdType="pubmed">29472250</ArticleId></ArticleIdList></Reference><Reference><Citation>Ambadipudi S, et al. Liquid-liquid phase separation of the microtubule-binding repeats of the Alzheimer-related protein Tau. Nat Commun. 2017;8(1):275. doi: 10.1038/s41467-017-00480-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-017-00480-0</ArticleId><ArticleId IdType="pmc">PMC5561136</ArticleId><ArticleId IdType="pubmed">28819146</ArticleId></ArticleIdList></Reference><Reference><Citation>Mathieu C, et al. Beyond aggregation: pathological phase transitions in neurodegenerative disease. Science. 2020;370(6512):56&#x2013;60. doi: 10.1126/science.abb8032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abb8032</ArticleId><ArticleId IdType="pmc">PMC8359821</ArticleId><ArticleId IdType="pubmed">33004511</ArticleId></ArticleIdList></Reference><Reference><Citation>Hallegger M, et al. TDP-43 condensation properties specify its RNA-binding and regulatory repertoire. Cell. 2021;184(18):4680&#x2013;4696. doi: 10.1016/j.cell.2021.07.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2021.07.018</ArticleId><ArticleId IdType="pmc">PMC8445024</ArticleId><ArticleId IdType="pubmed">34380047</ArticleId></ArticleIdList></Reference><Reference><Citation>Mann JR, et al. RNA binding antagonizes neurotoxic phase transitions of TDP-43. Neuron. 2019;102(2):321&#x2013;338. doi: 10.1016/j.neuron.2019.01.048.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2019.01.048</ArticleId><ArticleId IdType="pmc">PMC6472983</ArticleId><ArticleId IdType="pubmed">30826182</ArticleId></ArticleIdList></Reference><Reference><Citation>Nedelsky NB, Taylor JP. Bridging biophysics and neurology: aberrant phase transitions in neurodegenerative disease. Nat Rev Neurol. 2019;15(5):272&#x2013;286. doi: 10.1038/s41582-019-0157-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41582-019-0157-5</ArticleId><ArticleId IdType="pubmed">30890779</ArticleId></ArticleIdList></Reference><Reference><Citation>Alberti S, Hyman AA. Biomolecular condensates at the nexus of cellular stress, protein aggregation disease and ageing. Nat Rev Mol Cell Biol. 2021;22(3):196&#x2013;213. doi: 10.1038/s41580-020-00326-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41580-020-00326-6</ArticleId><ArticleId IdType="pubmed">33510441</ArticleId></ArticleIdList></Reference><Reference><Citation>Alberti S, Dormann D. Liquid-liquid phase separation in disease. Annu Rev Genet. 2019;53:171&#x2013;194. doi: 10.1146/annurev-genet-112618-043527.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-genet-112618-043527</ArticleId><ArticleId IdType="pubmed">31430179</ArticleId></ArticleIdList></Reference><Reference><Citation>Mittag T, Pappu RV. A conceptual framework for understanding phase separation and addressing open questions and challenges. Mol Cell. 2022;82(12):2201&#x2013;2214. doi: 10.1016/j.molcel.2022.05.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2022.05.018</ArticleId><ArticleId IdType="pmc">PMC9233049</ArticleId><ArticleId IdType="pubmed">35675815</ArticleId></ArticleIdList></Reference><Reference><Citation>Shin Y, Brangwynne CP. Liquid phase condensation in cell physiology and disease. Science. 2017;357(6357):eaaf4382. doi: 10.1126/science.aaf4382.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aaf4382</ArticleId><ArticleId IdType="pubmed">28935776</ArticleId></ArticleIdList></Reference><Reference><Citation>Li P, et al. Phase transitions in the assembly of multivalent signalling proteins. Nature. 2012;483(7389):336&#x2013;340. doi: 10.1038/nature10879.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature10879</ArticleId><ArticleId IdType="pmc">PMC3343696</ArticleId><ArticleId IdType="pubmed">22398450</ArticleId></ArticleIdList></Reference><Reference><Citation>Brangwynne CP, et al. Polymer physics of intracellular phase transitions. Nat Phys. 2015;11(11):899&#x2013;904. doi: 10.1038/nphys3532.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nphys3532</ArticleId></ArticleIdList></Reference><Reference><Citation>Lyon AS, et al. A framework for understanding the functions of biomolecular condensates across scales. Nat Rev Mol Cell Biol. 2021;22(3):215&#x2013;235. doi: 10.1038/s41580-020-00303-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41580-020-00303-z</ArticleId><ArticleId IdType="pmc">PMC8574987</ArticleId><ArticleId IdType="pubmed">33169001</ArticleId></ArticleIdList></Reference><Reference><Citation>Shimobayashi SF, et al. Nucleation landscape of biomolecular condensates. Nature. 2021;599(7885):503&#x2013;506. doi: 10.1038/s41586-021-03905-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03905-5</ArticleId><ArticleId IdType="pubmed">34552246</ArticleId></ArticleIdList></Reference><Reference><Citation>Snead WT, Gladfelter AS. The control centers of biomolecular phase separation: how membrane surfaces, PTMs, and active processes regulate condensation. Mol Cell. 2019;76(2):295&#x2013;305. doi: 10.1016/j.molcel.2019.09.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2019.09.016</ArticleId><ArticleId IdType="pmc">PMC7173186</ArticleId><ArticleId IdType="pubmed">31604601</ArticleId></ArticleIdList></Reference><Reference><Citation>Banani SF, et al. Compositional control of phase-separated cellular bodies. Cell. 2016;166(3):651&#x2013;663. doi: 10.1016/j.cell.2016.06.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2016.06.010</ArticleId><ArticleId IdType="pmc">PMC4967043</ArticleId><ArticleId IdType="pubmed">27374333</ArticleId></ArticleIdList></Reference><Reference><Citation>Banani SF, et al. Biomolecular condensates: organizers of cellular biochemistry. Nat Rev Mol Cell Biol. 2017;18(5):285&#x2013;298. doi: 10.1038/nrm.2017.7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrm.2017.7</ArticleId><ArticleId IdType="pmc">PMC7434221</ArticleId><ArticleId IdType="pubmed">28225081</ArticleId></ArticleIdList></Reference><Reference><Citation>Uversky VN, et al. Intrinsically disordered proteins in human diseases: introducing the D2 concept. Annu Rev Biophys. 2008;37:215&#x2013;246. doi: 10.1146/annurev.biophys.37.032807.125924.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.biophys.37.032807.125924</ArticleId><ArticleId IdType="pubmed">18573080</ArticleId></ArticleIdList></Reference><Reference><Citation>Darling AL, et al. Intrinsic disorder-based emergence in cellular biology: physiological and pathological liquid-liquid phase transitions in cells. Polymers (Basel) 2019;11(6):990. doi: 10.3390/polym11060990.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/polym11060990</ArticleId><ArticleId IdType="pmc">PMC6631845</ArticleId><ArticleId IdType="pubmed">31167414</ArticleId></ArticleIdList></Reference><Reference><Citation>Peran I, Mittag T. Molecular structure in biomolecular condensates. Curr Opin Struct Biol. 2020;60:17&#x2013;26. doi: 10.1016/j.sbi.2019.09.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.sbi.2019.09.007</ArticleId><ArticleId IdType="pmc">PMC7117980</ArticleId><ArticleId IdType="pubmed">31790873</ArticleId></ArticleIdList></Reference><Reference><Citation>Tziortzouda P, et al. Triad of TDP43 control in neurodegeneration: autoregulation, localization and aggregation. Nat Rev Neurosci. 2021;22(4):197&#x2013;208. doi: 10.1038/s41583-021-00431-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41583-021-00431-1</ArticleId><ArticleId IdType="pubmed">33654312</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X, et al. The proline-rich domain and the microtubule binding domain of protein tau acting as RNA binding domains. Protein Pept Lett. 2006;13(7):679&#x2013;685. doi: 10.2174/092986606777790566.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/092986606777790566</ArticleId><ArticleId IdType="pubmed">17018010</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X, et al. The proline-rich domain promotes Tau liquid-liquid phase separation in cells. J Cell Biol. 2020;219(11):e202006054. doi: 10.1083/jcb.202006054.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.202006054</ArticleId><ArticleId IdType="pmc">PMC7594490</ArticleId><ArticleId IdType="pubmed">32997736</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruff KM, et al. Polyphasic linkage and the impact of ligand binding on the regulation of biomolecular condensates. Biophys Rev (Melville) 2021;2(2):021302. doi: 10.1063/5.0050059.</Citation><ArticleIdList><ArticleId IdType="doi">10.1063/5.0050059</ArticleId><ArticleId IdType="pmc">PMC8211317</ArticleId><ArticleId IdType="pubmed">34179888</ArticleId></ArticleIdList></Reference><Reference><Citation>Boija A, et al. Biomolecular condensates and cancer. Cancer Cell. 2021;39(2):174&#x2013;192. doi: 10.1016/j.ccell.2020.12.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ccell.2020.12.003</ArticleId><ArticleId IdType="pmc">PMC8721577</ArticleId><ArticleId IdType="pubmed">33417833</ArticleId></ArticleIdList></Reference><Reference><Citation>Hofweber M, Dormann D. Friend or foe&#x2014;post-translational modifications as regulators of phase separation and RNP granule dynamics. J Biol Chem. 2019;294(18):7137&#x2013;7150. doi: 10.1074/jbc.TM118.001189.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.TM118.001189</ArticleId><ArticleId IdType="pmc">PMC6509508</ArticleId><ArticleId IdType="pubmed">30587571</ArticleId></ArticleIdList></Reference><Reference><Citation>Peng C, et al. Protein transmission in neurodegenerative disease. Nat Rev Neurol. 2020;16(4):199&#x2013;212. doi: 10.1038/s41582-020-0333-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41582-020-0333-7</ArticleId><ArticleId IdType="pmc">PMC9242841</ArticleId><ArticleId IdType="pubmed">32203399</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiti F, Dobson CM. Protein misfolding, amyloid formation, and human disease: a summary of progress over the last decade. Annu Rev Biochem. 2017;86:27&#x2013;68. doi: 10.1146/annurev-biochem-061516-045115.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-biochem-061516-045115</ArticleId><ArticleId IdType="pubmed">28498720</ArticleId></ArticleIdList></Reference><Reference><Citation>Knowles TPJ, et al. The amyloid state and its association with protein misfolding diseases. Nat Rev Mol Cell Biol. 2014;15(6):384&#x2013;396. doi: 10.1038/nrm3810.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrm3810</ArticleId><ArticleId IdType="pubmed">24854788</ArticleId></ArticleIdList></Reference><Reference><Citation>Dujardin S, et al. Tau molecular diversity contributes to clinical heterogeneity in Alzheimer&#x2019;s disease. Nat Med. 2020;26(8):1256&#x2013;1263. doi: 10.1038/s41591-020-0938-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-0938-9</ArticleId><ArticleId IdType="pmc">PMC7603860</ArticleId><ArticleId IdType="pubmed">32572268</ArticleId></ArticleIdList></Reference><Reference><Citation>Gibbons GS, et al. Mechanisms of cell-to-cell transmission of pathological tau: a review. JAMA Neurol. 2019;76(1):101&#x2013;108. doi: 10.1001/jamaneurol.2018.2505.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2018.2505</ArticleId><ArticleId IdType="pmc">PMC6382549</ArticleId><ArticleId IdType="pubmed">30193298</ArticleId></ArticleIdList></Reference><Reference><Citation>Fitzpatrick AWP, et al. Cryo-EM structures of tau filaments from Alzheimer&#x2019;s disease. Nature. 2017;547(7662):185&#x2013;190. doi: 10.1038/nature23002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature23002</ArticleId><ArticleId IdType="pmc">PMC5552202</ArticleId><ArticleId IdType="pubmed">28678775</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao Q, et al. Cryo-EM structures of four polymorphic TDP-43 amyloid cores. Nat Struct Mol Biol. 2019;26(7):619&#x2013;627. doi: 10.1038/s41594-019-0248-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41594-019-0248-4</ArticleId><ArticleId IdType="pmc">PMC7047951</ArticleId><ArticleId IdType="pubmed">31235914</ArticleId></ArticleIdList></Reference><Reference><Citation>Arakhamia T, et al. Posttranslational modifications mediate the structural diversity of tauopathy strains. Cell. 2020;180(4):633&#x2013;644. doi: 10.1016/j.cell.2020.01.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.01.027</ArticleId><ArticleId IdType="pmc">PMC7491959</ArticleId><ArticleId IdType="pubmed">32032505</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang YS, et al. Full-length TDP-43 forms toxic amyloid oligomers that are present in frontotemporal lobar dementia-TDP patients. Nat Commun. 2014;5:4824. doi: 10.1038/ncomms5824.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms5824</ArticleId><ArticleId IdType="pubmed">25215604</ArticleId></ArticleIdList></Reference><Reference><Citation>Lye YS, Chen Y-R. TAR DNA-binding protein 43 oligomers in physiology and pathology. IUBMB Life. 2022;74(8):794&#x2013;811. doi: 10.1002/iub.2603.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/iub.2603</ArticleId><ArticleId IdType="pubmed">35229461</ArticleId></ArticleIdList></Reference><Reference><Citation>Li D, Liu C. Hierarchical chemical determination of amyloid polymorphs in neurodegenerative disease. Nat Chem Biol. 2021;17(3):237&#x2013;245. doi: 10.1038/s41589-020-00708-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41589-020-00708-z</ArticleId><ArticleId IdType="pubmed">33432239</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi Y, et al. Structure-based classification of tauopathies. Nature. 2021;598(7880):359&#x2013;363. doi: 10.1038/s41586-021-03911-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03911-7</ArticleId><ArticleId IdType="pmc">PMC7611841</ArticleId><ArticleId IdType="pubmed">34588692</ArticleId></ArticleIdList></Reference><Reference><Citation>Arseni D, et al. Structure of pathological TDP-43 filaments from ALS with FTLD. Nature. 2022;601(7891):139&#x2013;143. doi: 10.1038/s41586-021-04199-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-04199-3</ArticleId><ArticleId IdType="pmc">PMC7612255</ArticleId><ArticleId IdType="pubmed">34880495</ArticleId></ArticleIdList></Reference><Reference><Citation>Laferri&#xe8;re F, et al. TDP-43 extracted from frontotemporal lobar degeneration subject brains displays distinct aggregate assemblies and neurotoxic effects reflecting disease progression rates. Nat Neurosci. 2019;22(1):65&#x2013;77. doi: 10.1038/s41593-018-0294-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-018-0294-y</ArticleId><ArticleId IdType="pubmed">30559480</ArticleId></ArticleIdList></Reference><Reference><Citation>Hughes MP, et al. Prevalence and species distribution of the low-complexity, amyloid-like, reversible, kinked segment structural motif in amyloid-like fibrils. J Biol Chem. 2021;297(4):101194. doi: 10.1016/j.jbc.2021.101194.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbc.2021.101194</ArticleId><ArticleId IdType="pmc">PMC8551513</ArticleId><ArticleId IdType="pubmed">34537246</ArticleId></ArticleIdList></Reference><Reference><Citation>Guenther EL, et al. Atomic structures of TDP-43 LCD segments and insights into reversible or pathogenic aggregation. Nat Struct Mol Biol. 2018;25(6):463&#x2013;471. doi: 10.1038/s41594-018-0064-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41594-018-0064-2</ArticleId><ArticleId IdType="pmc">PMC5990464</ArticleId><ArticleId IdType="pubmed">29786080</ArticleId></ArticleIdList></Reference><Reference><Citation>Houben B, et al. Protein structure and aggregation: a marriage of necessity ruled by aggregation gatekeepers. Trends Biochem Sci. 2022;47(3):194&#x2013;205. doi: 10.1016/j.tibs.2021.08.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tibs.2021.08.010</ArticleId><ArticleId IdType="pubmed">34561149</ArticleId></ArticleIdList></Reference><Reference><Citation>Eschmann NA, et al. Signature of an aggregation-prone conformation of tau. Sci Rep. 2017;7:44739. doi: 10.1038/srep44739.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep44739</ArticleId><ArticleId IdType="pmc">PMC5356194</ArticleId><ArticleId IdType="pubmed">28303942</ArticleId></ArticleIdList></Reference><Reference><Citation>Fitzpatrick AW, Saibil HR. Cryo-EM of amyloid fibrils and cellular aggregates. Curr Opin Struct Biol. 2019;58:34&#x2013;42. doi: 10.1016/j.sbi.2019.05.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.sbi.2019.05.003</ArticleId><ArticleId IdType="pmc">PMC6778506</ArticleId><ArticleId IdType="pubmed">31200186</ArticleId></ArticleIdList></Reference><Reference><Citation>Staderini T, et al. Biophysical characterization of full-length TAR DNA-binding protein (TDP-43) phase separation. Protein Sci. 2022;e4509(12):e4509. doi: 10.1002/pro.4509.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pro.4509</ArticleId><ArticleId IdType="pmc">PMC9703588</ArticleId><ArticleId IdType="pubmed">36371546</ArticleId></ArticleIdList></Reference><Reference><Citation>Li HR, et al. The physical forces mediating self-association and phase-separation in the C-terminal domain of TDP-43. Biochim Biophys Acta Proteins Proteom. 2018;1866(2):214&#x2013;223. doi: 10.1016/j.bbapap.2017.10.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbapap.2017.10.001</ArticleId><ArticleId IdType="pubmed">28988034</ArticleId></ArticleIdList></Reference><Reference><Citation>Babinchak WM, et al. The role of liquid-liquid phase separation in aggregation of the TDP-43 low-complexity domain. J Biol Chem. 2019;294(16):6306&#x2013;6317. doi: 10.1074/jbc.RA118.007222.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.RA118.007222</ArticleId><ArticleId IdType="pmc">PMC6484124</ArticleId><ArticleId IdType="pubmed">30814253</ArticleId></ArticleIdList></Reference><Reference><Citation>Conicella AE, et al. ALS mutations disrupt phase separation mediated by &#x3b1;-helical structure in the TDP-43 low-complexity C-terminal domain. Structure. 2016;24(9):1537&#x2013;1549. doi: 10.1016/j.str.2016.07.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.str.2016.07.007</ArticleId><ArticleId IdType="pmc">PMC5014597</ArticleId><ArticleId IdType="pubmed">27545621</ArticleId></ArticleIdList></Reference><Reference><Citation>Alami NH, et al. Axonal transport of TDP-43 mRNA granules is impaired by ALS-causing mutations. Neuron. 2014;81(3):536&#x2013;543. doi: 10.1016/j.neuron.2013.12.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2013.12.018</ArticleId><ArticleId IdType="pmc">PMC3939050</ArticleId><ArticleId IdType="pubmed">24507191</ArticleId></ArticleIdList></Reference><Reference><Citation>Prasad A, et al. Molecular mechanisms of TDP-43 misfolding and pathology in amyotrophic lateral sclerosis. Front Mol Neurosci. 2019;12:25. doi: 10.3389/fnmol.2019.00025.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2019.00025</ArticleId><ArticleId IdType="pmc">PMC6382748</ArticleId><ArticleId IdType="pubmed">30837838</ArticleId></ArticleIdList></Reference><Reference><Citation>Gopal PP, et al. Amyotrophic lateral sclerosis-linked mutations increase the viscosity of liquid-like TDP-43 RNP granules in neurons. Proc Natl Acad Sci U S A. 2017;114(12):E2466&#x2013;E2475. doi: 10.1073/pnas.1614462114.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1614462114</ArticleId><ArticleId IdType="pmc">PMC5373408</ArticleId><ArticleId IdType="pubmed">28265061</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeng YT, et al. Different intermolecular interactions drive nonpathogenic liquid-liquid phase separation and potentially pathogenic fibril formation by TDP-43. Int J Mol Sci. 2022;23(23):15227. doi: 10.3390/ijms232315227.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms232315227</ArticleId><ArticleId IdType="pmc">PMC9741235</ArticleId><ArticleId IdType="pubmed">36499553</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruff KM, et al. Ligand effects on phase separation of multivalent macromolecules. Proc Natl Acad Sci U S A. 2021;118(10):e2017184118. doi: 10.1073/pnas.2017184118.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2017184118</ArticleId><ArticleId IdType="pmc">PMC7958451</ArticleId><ArticleId IdType="pubmed">33653957</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi J-M, et al. Physical principles underlying the complex biology of intracellular phase transitions. Annu Rev Biophys. 2020;49:107&#x2013;133. doi: 10.1146/annurev-biophys-121219-081629.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-biophys-121219-081629</ArticleId><ArticleId IdType="pubmed">32004090</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Treeck B, Parker R. Emerging roles for intermolecular RNA-RNA interactions in RNP assemblies. Cell. 2018;174(4):791&#x2013;802. doi: 10.1016/j.cell.2018.07.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2018.07.023</ArticleId><ArticleId IdType="pmc">PMC6200146</ArticleId><ArticleId IdType="pubmed">30096311</ArticleId></ArticleIdList></Reference><Reference><Citation>Grese ZR, et al. Specific RNA interactions promote TDP-43 multivalent phase separation and maintain liquid properties. EMBO Rep. 2021;22(12):e53632. doi: 10.15252/embr.202153632.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embr.202153632</ArticleId><ArticleId IdType="pmc">PMC8647020</ArticleId><ArticleId IdType="pubmed">34787357</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia-Jove Navarro M, et al. RNA is a critical element for the sizing and the composition of phase-separated RNA-protein condensates. Nat Commun. 2019;10(1):3230. doi: 10.1038/s41467-019-11241-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-019-11241-6</ArticleId><ArticleId IdType="pmc">PMC6642089</ArticleId><ArticleId IdType="pubmed">31324804</ArticleId></ArticleIdList></Reference><Reference><Citation>Lewis CJT, et al. RNA modifications and structures cooperate to guide RNA-protein interactions. Nat Rev Mol Cell Biol. 2017;18(3):202&#x2013;210. doi: 10.1038/nrm.2016.163.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrm.2016.163</ArticleId><ArticleId IdType="pmc">PMC5542016</ArticleId><ArticleId IdType="pubmed">28144031</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanders DW, et al. Competing protein-RNA interaction networks control multiphase intracellular organization. Cell. 2020;181(2):306&#x2013;324. doi: 10.1016/j.cell.2020.03.050.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.03.050</ArticleId><ArticleId IdType="pmc">PMC7816278</ArticleId><ArticleId IdType="pubmed">32302570</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Treeck B, et al. RNA self-assembly contributes to stress granule formation and defining the stress granule transcriptome. Proc Natl Acad Sci U S A. 2018;115(11):2734&#x2013;2739. doi: 10.1073/pnas.1800038115.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1800038115</ArticleId><ArticleId IdType="pmc">PMC5856561</ArticleId><ArticleId IdType="pubmed">29483269</ArticleId></ArticleIdList></Reference><Reference><Citation>Roden C, Gladfelter AS. RNA contributions to the form and function of biomolecular condensates. Nat Rev Mol Cell Biol. 2021;22(3):183&#x2013;195. doi: 10.1038/s41580-020-0264-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41580-020-0264-6</ArticleId><ArticleId IdType="pmc">PMC7785677</ArticleId><ArticleId IdType="pubmed">32632317</ArticleId></ArticleIdList></Reference><Reference><Citation>Aarum J, et al. Enzymatic degradation of RNA causes widespread protein aggregation in cell and tissue lysates. EMBO Rep. 2020;21(10):e49585. doi: 10.15252/embr.201949585.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embr.201949585</ArticleId><ArticleId IdType="pmc">PMC7534620</ArticleId><ArticleId IdType="pubmed">32945072</ArticleId></ArticleIdList></Reference><Reference><Citation>Mann JR, Donnelly CJ. RNA modulates physiological and neuropathological protein phase transitions. Neuron. 2021;109(17):2663&#x2013;2681. doi: 10.1016/j.neuron.2021.06.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2021.06.023</ArticleId><ArticleId IdType="pmc">PMC8434763</ArticleId><ArticleId IdType="pubmed">34297914</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X, et al. RNA stores tau reversibly in complex coacervates. PLoS Biol. 2017;15(7):e2002183. doi: 10.1371/journal.pbio.2002183.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pbio.2002183</ArticleId><ArticleId IdType="pmc">PMC5500003</ArticleId><ArticleId IdType="pubmed">28683104</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin EW, et al. Valence and patterning of aromatic residues determine the phase behavior of prion-like domains. Science. 2020;367(6478):694&#x2013;699. doi: 10.1126/science.aaw8653.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aaw8653</ArticleId><ArticleId IdType="pmc">PMC7297187</ArticleId><ArticleId IdType="pubmed">32029630</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu X, et al. Liquid-liquid phase separation in neuronal development and synaptic signaling. Dev Cell. 2020;55(1):18&#x2013;29. doi: 10.1016/j.devcel.2020.06.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.devcel.2020.06.012</ArticleId><ArticleId IdType="pubmed">32726576</ArticleId></ArticleIdList></Reference><Reference><Citation>McDonald NA, et al. Assembly of synaptic active zones requires phase separation of scaffold molecules. Nature. 2020;588(7838):454&#x2013;458. doi: 10.1038/s41586-020-2942-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2942-0</ArticleId><ArticleId IdType="pubmed">33208945</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryan VH, Fawzi NL. Physiological, pathological, and targetable membraneless organelles in neurons. Trends Neurosci. 2019;42(10):693&#x2013;708. doi: 10.1016/j.tins.2019.08.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tins.2019.08.005</ArticleId><ArticleId IdType="pmc">PMC6779520</ArticleId><ArticleId IdType="pubmed">31493925</ArticleId></ArticleIdList></Reference><Reference><Citation>Lacroix E, Audas TE. Keeping up with the condensates: the retention, gain, and loss of nuclear membrane-less organelles. Front Mol Biosci. 2022;9:998363. doi: 10.3389/fmolb.2022.998363.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmolb.2022.998363</ArticleId><ArticleId IdType="pmc">PMC9530788</ArticleId><ArticleId IdType="pubmed">36203874</ArticleId></ArticleIdList></Reference><Reference><Citation>Su Q, et al. Liquid-liquid phase separation: orchestrating cell signaling through time and space. Mol Cell. 2021;81(20):4137&#x2013;4146. doi: 10.1016/j.molcel.2021.09.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2021.09.010</ArticleId><ArticleId IdType="pmc">PMC8541918</ArticleId><ArticleId IdType="pubmed">34619090</ArticleId></ArticleIdList></Reference><Reference><Citation>Shin Y, et al. Liquid nuclear condensates mechanically sense and restructure the genome. Cell. 2018;175(6):1481&#x2013;1491. doi: 10.1016/j.cell.2018.10.057.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2018.10.057</ArticleId><ArticleId IdType="pmc">PMC6724728</ArticleId><ArticleId IdType="pubmed">30500535</ArticleId></ArticleIdList></Reference><Reference><Citation>Sabari BR, et al. Biomolecular condensates in the nucleus. Trends Biochem Sci. 2020;45(11):961&#x2013;977. doi: 10.1016/j.tibs.2020.06.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tibs.2020.06.007</ArticleId><ArticleId IdType="pmc">PMC7572565</ArticleId><ArticleId IdType="pubmed">32684431</ArticleId></ArticleIdList></Reference><Reference><Citation>Ishov AM, et al. Coordination of transcription, processing, and export of highly expressed RNAs by distinct biomolecular condensates. Emerg Top Life Sci. 2020;4(3):281&#x2013;291. doi: 10.1042/ETLS20190160.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/ETLS20190160</ArticleId><ArticleId IdType="pmc">PMC7733674</ArticleId><ArticleId IdType="pubmed">32338276</ArticleId></ArticleIdList></Reference><Reference><Citation>Frottin F, et al. The nucleolus functions as a phase-separated protein quality control compartment. Science. 2019;365(6451):342&#x2013;347. doi: 10.1126/science.aaw9157.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aaw9157</ArticleId><ArticleId IdType="pubmed">31296649</ArticleId></ArticleIdList></Reference><Reference><Citation>Henninger JE, et al. RNA-mediated feedback control of transcriptional condensates. Cell. 2021;184(1):207&#x2013;225. doi: 10.1016/j.cell.2020.11.030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.11.030</ArticleId><ArticleId IdType="pmc">PMC8128340</ArticleId><ArticleId IdType="pubmed">33333019</ArticleId></ArticleIdList></Reference><Reference><Citation>Lafontaine DLJ, et al. The nucleolus as a multiphase liquid condensate. Nat Rev Mol Cell Biol. 2021;22(3):165&#x2013;182. doi: 10.1038/s41580-020-0272-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41580-020-0272-6</ArticleId><ArticleId IdType="pubmed">32873929</ArticleId></ArticleIdList></Reference><Reference><Citation>Audas TE, et al. Immobilization of proteins in the nucleolus by ribosomal intergenic spacer noncoding RNA. Mol Cell. 2012;45(2):147&#x2013;157. doi: 10.1016/j.molcel.2011.12.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2011.12.012</ArticleId><ArticleId IdType="pubmed">22284675</ArticleId></ArticleIdList></Reference><Reference><Citation>Feric M, et al. Coexisting liquid phases underlie nucleolar subcompartments. Cell. 2016;165(7):1686&#x2013;1697. doi: 10.1016/j.cell.2016.04.047.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2016.04.047</ArticleId><ArticleId IdType="pmc">PMC5127388</ArticleId><ArticleId IdType="pubmed">27212236</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharp PA, et al. RNA in formation and regulation of transcriptional condensates. RNA. 2022;28(1):52&#x2013;57. doi: 10.1261/rna.078997.121.</Citation><ArticleIdList><ArticleId IdType="doi">10.1261/rna.078997.121</ArticleId><ArticleId IdType="pmc">PMC8675292</ArticleId><ArticleId IdType="pubmed">34772787</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo YE, et al. Pol II phosphorylation regulates a switch between transcriptional and splicing condensates. Nature. 2019;572(7770):543&#x2013;548. doi: 10.1038/s41586-019-1464-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-019-1464-0</ArticleId><ArticleId IdType="pmc">PMC6706314</ArticleId><ArticleId IdType="pubmed">31391587</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein IA, et al. Partitioning of cancer therapeutics in nuclear condensates. Science. 2020;368(6497):1386&#x2013;1392. doi: 10.1126/science.aaz4427.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aaz4427</ArticleId><ArticleId IdType="pmc">PMC7735713</ArticleId><ArticleId IdType="pubmed">32554597</ArticleId></ArticleIdList></Reference><Reference><Citation>Gibson BA, et al. Organization of chromatin by intrinsic and regulated phase separation. Cell. 2019;179(2):470&#x2013;484. doi: 10.1016/j.cell.2019.08.037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2019.08.037</ArticleId><ArticleId IdType="pmc">PMC6778041</ArticleId><ArticleId IdType="pubmed">31543265</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolozin B, Ivanov P. Stress granules and neurodegeneration. Nat Rev Neurosci. 2019;20(11):649&#x2013;666. doi: 10.1038/s41583-019-0222-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41583-019-0222-5</ArticleId><ArticleId IdType="pmc">PMC6986315</ArticleId><ArticleId IdType="pubmed">31582840</ArticleId></ArticleIdList></Reference><Reference><Citation>Molliex A, et al. Phase separation by low complexity domains promotes stress granule assembly and drives pathological fibrillization. Cell. 2015;163(1):123&#x2013;133. doi: 10.1016/j.cell.2015.09.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2015.09.015</ArticleId><ArticleId IdType="pmc">PMC5149108</ArticleId><ArticleId IdType="pubmed">26406374</ArticleId></ArticleIdList></Reference><Reference><Citation>Glauninger H, et al. Stressful steps: progress and challenges in understanding stress-induced mRNA condensation and accumulation in stress granules. Mol Cell. 2022;82(14):2544&#x2013;2556. doi: 10.1016/j.molcel.2022.05.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2022.05.014</ArticleId><ArticleId IdType="pmc">PMC9308734</ArticleId><ArticleId IdType="pubmed">35662398</ArticleId></ArticleIdList></Reference><Reference><Citation>Gasset-Rosa F, et al. Cytoplasmic TDP-43 de-mixing independent of stress granules drives inhibition of nuclear import, loss of nuclear TDP-43, and cell death. Neuron. 2019;102(2):339&#x2013;357. doi: 10.1016/j.neuron.2019.02.038.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2019.02.038</ArticleId><ArticleId IdType="pmc">PMC6548321</ArticleId><ArticleId IdType="pubmed">30853299</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackenzie IR, et al. TIA1 mutations in amyotrophic lateral sclerosis and frontotemporal dementia promote phase separation and alter stress granule dynamics. Neuron. 2017;95(4):808&#x2013;816. doi: 10.1016/j.neuron.2017.07.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2017.07.025</ArticleId><ArticleId IdType="pmc">PMC5576574</ArticleId><ArticleId IdType="pubmed">28817800</ArticleId></ArticleIdList></Reference><Reference><Citation>Markmiller S, et al. Context-dependent and disease-specific diversity in protein interactions within stress granules. Cell. 2018;172(3):590&#x2013;604. doi: 10.1016/j.cell.2017.12.032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2017.12.032</ArticleId><ArticleId IdType="pmc">PMC5969999</ArticleId><ArticleId IdType="pubmed">29373831</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang P, et al. G3BP1 is a tunable switch that triggers phase separation to assemble stress granules. Cell. 2020;181(2):325&#x2013;345. doi: 10.1016/j.cell.2020.03.046.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.03.046</ArticleId><ArticleId IdType="pmc">PMC7448383</ArticleId><ArticleId IdType="pubmed">32302571</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayashi Y, et al. Liquid-liquid phase separation in physiology and pathophysiology of the nervous system. J Neurosci. 2021;41(5):834&#x2013;844. doi: 10.1523/JNEUROSCI.1656-20.2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.1656-20.2020</ArticleId><ArticleId IdType="pmc">PMC7880275</ArticleId><ArticleId IdType="pubmed">33472825</ArticleId></ArticleIdList></Reference><Reference><Citation>Milovanovic D, De Camilli P. Synaptic vesicle clusters at synapses: a distinct liquid phase? Neuron. 2017;93(5):995&#x2013;1002. doi: 10.1016/j.neuron.2017.02.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2017.02.013</ArticleId><ArticleId IdType="pmc">PMC5347463</ArticleId><ArticleId IdType="pubmed">28279363</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu X, et al. Interactions between membraneless condensates and membranous organelles at the presynapse: a phase separation view of synaptic vesicle cycle. J Mol Biol. 2022;167629(1):167629. doi: 10.1016/j.jmb.2022.167629.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmb.2022.167629</ArticleId><ArticleId IdType="pubmed">35595170</ArticleId></ArticleIdList></Reference><Reference><Citation>Milovanovic D, et al. A liquid phase of synapsin and lipid vesicles. Science. 2018;361(6402):604&#x2013;607. doi: 10.1126/science.aat5671.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aat5671</ArticleId><ArticleId IdType="pmc">PMC6191856</ArticleId><ArticleId IdType="pubmed">29976799</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeng M, et al. Phase transition in postsynaptic densities underlies formation of synaptic complexes and synaptic plasticity. Cell. 2016;166(5):1163&#x2013;1175. doi: 10.1016/j.cell.2016.07.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2016.07.008</ArticleId><ArticleId IdType="pmc">PMC5564291</ArticleId><ArticleId IdType="pubmed">27565345</ArticleId></ArticleIdList></Reference><Reference><Citation>Bourke AM, et al. De-centralizing the central dogma: mRNA translation in space and time. Mol Cell. 2023;83(3):452&#x2013;468. doi: 10.1016/j.molcel.2022.12.030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2022.12.030</ArticleId><ArticleId IdType="pubmed">36669490</ArticleId></ArticleIdList></Reference><Reference><Citation>Parker DM, et al. It&#x2019;s just a phase: exploring the relationship between mRNA, biomolecular condensates, and translational control. Front Genet. 2022;13:931220. doi: 10.3389/fgene.2022.931220.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fgene.2022.931220</ArticleId><ArticleId IdType="pmc">PMC9271857</ArticleId><ArticleId IdType="pubmed">35832192</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim TH, et al. Phospho-dependent phase separation of FMRP and CAPRIN1 recapitulates regulation of translation and deadenylation. Science. 2019;365(6455):825&#x2013;829. doi: 10.1126/science.aax4240.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aax4240</ArticleId><ArticleId IdType="pubmed">31439799</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan R, et al. Microtubules gate tau condensation to spatially regulate microtubule functions. Nat Cell Biol. 2019;21(9):1078&#x2013;1085. doi: 10.1038/s41556-019-0375-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41556-019-0375-5</ArticleId><ArticleId IdType="pmc">PMC6748660</ArticleId><ArticleId IdType="pubmed">31481790</ArticleId></ArticleIdList></Reference><Reference><Citation>Hern&#xe1;ndez-Vega A, et al. Local nucleation of microtubule bundles through tubulin concentration into a condensed tau phase. Cell Rep. 2017;20(10):2304&#x2013;2312. doi: 10.1016/j.celrep.2017.08.042.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2017.08.042</ArticleId><ArticleId IdType="pmc">PMC5828996</ArticleId><ArticleId IdType="pubmed">28877466</ArticleId></ArticleIdList></Reference><Reference><Citation>Hochmair J, et al. Molecular crowding and RNA synergize to promote phase separation, microtubule interaction, and seeding of tau condensates. EMBO J. 2022;41(11):e108882. doi: 10.15252/embj.2021108882.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.2021108882</ArticleId><ArticleId IdType="pmc">PMC9156969</ArticleId><ArticleId IdType="pubmed">35298090</ArticleId></ArticleIdList></Reference><Reference><Citation>Maina MB, et al. The involvement of tau in nucleolar transcription and the stress response. Acta Neuropathol Commun. 2018;6(1):70. doi: 10.1186/s40478-018-0565-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-018-0565-6</ArticleId><ArticleId IdType="pmc">PMC6066928</ArticleId><ArticleId IdType="pubmed">30064522</ArticleId></ArticleIdList></Reference><Reference><Citation>Tracy TE, et al. Tau interactome maps synaptic and mitochondrial processes associated with neurodegeneration. Cell. 2022;185(4):712&#x2013;728. doi: 10.1016/j.cell.2021.12.041.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2021.12.041</ArticleId><ArticleId IdType="pmc">PMC8857049</ArticleId><ArticleId IdType="pubmed">35063084</ArticleId></ArticleIdList></Reference><Reference><Citation>Freibaum BD, et al. Global analysis of TDP-43 interacting proteins reveals strong association with RNA splicing and translation machinery. J Proteome Res. 2010;9(2):1104&#x2013;1120. doi: 10.1021/pr901076y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/pr901076y</ArticleId><ArticleId IdType="pmc">PMC2897173</ArticleId><ArticleId IdType="pubmed">20020773</ArticleId></ArticleIdList></Reference><Reference><Citation>Kavanagh T, et al. Tau interactome and RNA binding proteins in neurodegenerative diseases. Mol Neurodegener. 2022;17(1):66. doi: 10.1186/s13024-022-00572-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-022-00572-6</ArticleId><ArticleId IdType="pmc">PMC9575286</ArticleId><ArticleId IdType="pubmed">36253823</ArticleId></ArticleIdList></Reference><Reference><Citation>Ittner A, Ittner LM. Dendritic tau in Alzheimer&#x2019;s disease. Neuron. 2018;99(1):13&#x2013;27. doi: 10.1016/j.neuron.2018.06.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2018.06.003</ArticleId><ArticleId IdType="pubmed">30001506</ArticleId></ArticleIdList></Reference><Reference><Citation>DeVos SL, et al. Synaptic tau seeding precedes tau pathology in human Alzheimer&#x2019;s disease brain. Front Neurosci. 2018;12:267. doi: 10.3389/fnins.2018.00267.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2018.00267</ArticleId><ArticleId IdType="pmc">PMC5928393</ArticleId><ArticleId IdType="pubmed">29740275</ArticleId></ArticleIdList></Reference><Reference><Citation>McInnes J, et al. Synaptogyrin-3 mediates presynaptic dysfunction induced by tau. Neuron. 2018;97(4):823&#x2013;835. doi: 10.1016/j.neuron.2018.01.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2018.01.022</ArticleId><ArticleId IdType="pubmed">29398363</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee EB, et al. Gains or losses: molecular mechanisms of TDP43-mediated neurodegeneration. Nat Rev Neurosci. 2012;13(1):38&#x2013;50. doi: 10.1038/nrn3121.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrn3121</ArticleId><ArticleId IdType="pmc">PMC3285250</ArticleId><ArticleId IdType="pubmed">22127299</ArticleId></ArticleIdList></Reference><Reference><Citation>Afroz T, et al. Functional and dynamic polymerization of the ALS-linked protein TDP-43 antagonizes its pathologic aggregation. Nat Commun. 2017;8(1):45. doi: 10.1038/s41467-017-00062-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-017-00062-0</ArticleId><ArticleId IdType="pmc">PMC5491494</ArticleId><ArticleId IdType="pubmed">28663553</ArticleId></ArticleIdList></Reference><Reference><Citation>Sekar D, et al. TDP-43 and NEAT long non-coding RNA: roles in neurodegenerative disease. Front Cell Neurosci. 2022;16:954912. doi: 10.3389/fncel.2022.954912.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2022.954912</ArticleId><ArticleId IdType="pmc">PMC9650703</ArticleId><ArticleId IdType="pubmed">36385948</ArticleId></ArticleIdList></Reference><Reference><Citation>Banani SF, et al. Genetic variation associated with condensate dysregulation in disease. Dev Cell. 2022;57(14):1776&#x2013;1788. doi: 10.1016/j.devcel.2022.06.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.devcel.2022.06.010</ArticleId><ArticleId IdType="pmc">PMC9339523</ArticleId><ArticleId IdType="pubmed">35809564</ArticleId></ArticleIdList></Reference><Reference><Citation>Hou Y, et al. Ageing as a risk factor for neurodegenerative disease. Nat Rev Neurol. 2019;15(10):565&#x2013;581. doi: 10.1038/s41582-019-0244-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41582-019-0244-7</ArticleId><ArticleId IdType="pubmed">31501588</ArticleId></ArticleIdList></Reference><Reference><Citation>Soto-Palma C, et al. Epigenetics, DNA damage, and aging. J Clin Invest. 2022;132(16):158446. doi: 10.1172/JCI158446.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI158446</ArticleId><ArticleId IdType="pmc">PMC9374376</ArticleId><ArticleId IdType="pubmed">35968782</ArticleId></ArticleIdList></Reference><Reference><Citation>Donnelly CJ, et al. Aberrant RNA homeostasis in amyotrophic lateral sclerosis: potential for new therapeutic targets? Neurodegener Dis Manag. 2014;4(6):417&#x2013;437. doi: 10.2217/nmt.14.36.</Citation><ArticleIdList><ArticleId IdType="doi">10.2217/nmt.14.36</ArticleId><ArticleId IdType="pmc">PMC4308292</ArticleId><ArticleId IdType="pubmed">25531686</ArticleId></ArticleIdList></Reference><Reference><Citation>Spead O, et al. Nuclear pore dysfunction in neurodegeneration. Neurotherapeutics. 2022;19(4):1050&#x2013;1060. doi: 10.1007/s13311-022-01293-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13311-022-01293-w</ArticleId><ArticleId IdType="pmc">PMC9587172</ArticleId><ArticleId IdType="pubmed">36070178</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehta S, Zhang J. Liquid-liquid phase separation drives cellular function and dysfunction in cancer. Nat Rev Cancer. 2022;22(4):239&#x2013;252. doi: 10.1038/s41568-022-00444-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41568-022-00444-7</ArticleId><ArticleId IdType="pmc">PMC10036213</ArticleId><ArticleId IdType="pubmed">35149762</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsang B, et al. Phase separation as a missing mechanism for interpretation of disease mutations. Cell. 2020;183(7):1742&#x2013;1756. doi: 10.1016/j.cell.2020.11.050.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.11.050</ArticleId><ArticleId IdType="pubmed">33357399</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang H, et al. Liquid-liquid phase separation in biology: mechanisms, physiological functions and human diseases. Sci China Life Sci. 2020;63(7):953&#x2013;985. doi: 10.1007/s11427-020-1702-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11427-020-1702-x</ArticleId><ArticleId IdType="pubmed">32548680</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou X, et al. Mutations linked to neurological disease enhance self-association of low-complexity protein sequences. Science. 2022;377(6601):eabn5582. doi: 10.1126/science.abn5582.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abn5582</ArticleId><ArticleId IdType="pmc">PMC9610444</ArticleId><ArticleId IdType="pubmed">35771920</ArticleId></ArticleIdList></Reference><Reference><Citation>Nedelsky NB, Taylor JP. Pathological phase transitions in ALS-FTD impair dynamic RNA-protein granules. RNA. 2022;28(1):97&#x2013;113. doi: 10.1261/rna.079001.121.</Citation><ArticleIdList><ArticleId IdType="doi">10.1261/rna.079001.121</ArticleId><ArticleId IdType="pmc">PMC8675280</ArticleId><ArticleId IdType="pubmed">34706979</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim HJ, et al. Mutations in prion-like domains in hnRNPA2B1 and hnRNPA1 cause multisystem proteinopathy and ALS. Nature. 2013;495(7442):467&#x2013;473. doi: 10.1038/nature11922.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature11922</ArticleId><ArticleId IdType="pmc">PMC3756911</ArticleId><ArticleId IdType="pubmed">23455423</ArticleId></ArticleIdList></Reference><Reference><Citation>Maharana S, et al. RNA buffers the phase separation behavior of prion-like RNA binding proteins. Science. 2018;360(6391):918&#x2013;921. doi: 10.1126/science.aar7366.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aar7366</ArticleId><ArticleId IdType="pmc">PMC6091854</ArticleId><ArticleId IdType="pubmed">29650702</ArticleId></ArticleIdList></Reference><Reference><Citation>Maziuk B, et al. Dysregulation of RNA binding protein aggregation in neurodegenerative disorders. Front Mol Neurosci. 2017;10:89. doi: 10.3389/fnmol.2017.00089.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2017.00089</ArticleId><ArticleId IdType="pmc">PMC5378767</ArticleId><ArticleId IdType="pubmed">28420962</ArticleId></ArticleIdList></Reference><Reference><Citation>Niaki AG, et al. Loss of dynamic RNA interaction and aberrant phase separation induced by two distinct types of ALS/FTD-linked FUS mutations. Mol Cell. 2020;77(1):82&#x2013;94. doi: 10.1016/j.molcel.2019.09.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2019.09.022</ArticleId><ArticleId IdType="pmc">PMC6943187</ArticleId><ArticleId IdType="pubmed">31630970</ArticleId></ArticleIdList></Reference><Reference><Citation>Aguzzi A, Altmeyer M. Phase separation: linking cellular compartmentalization to disease. Trends Cell Biol. 2016;26(7):547&#x2013;558. doi: 10.1016/j.tcb.2016.03.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tcb.2016.03.004</ArticleId><ArticleId IdType="pubmed">27051975</ArticleId></ArticleIdList></Reference><Reference><Citation>Joel Z, et al. Improving mouse models for dementia. Are all the effects in tau mouse models due to overexpression? Cold Spring Harb Symp Quant Biol. 2018;83:151&#x2013;161. doi: 10.1101/sqb.2018.83.037531.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/sqb.2018.83.037531</ArticleId><ArticleId IdType="pubmed">30745408</ArticleId></ArticleIdList></Reference><Reference><Citation>Wood A, et al. Molecular mechanisms underlying TDP-43 pathology in cellular and animal models of ALS and FTLD. Int J Mol Sci. 2021;22(9):4705. doi: 10.3390/ijms22094705.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22094705</ArticleId><ArticleId IdType="pmc">PMC8125728</ArticleId><ArticleId IdType="pubmed">33946763</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown AL, et al. TDP-43 loss and ALS-risk SNPs drive mis-splicing and depletion of UNC13A. Nature. 2022;603(7899):131&#x2013;137. doi: 10.1038/s41586-022-04436-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-04436-3</ArticleId><ArticleId IdType="pmc">PMC8891020</ArticleId><ArticleId IdType="pubmed">35197628</ArticleId></ArticleIdList></Reference><Reference><Citation>DeVos SL, et al. Tau reduction in the presence of amyloid-&#x3b2; prevents tau pathology and neuronal death in vivo. Brain. 2018;141(7):2194&#x2013;2212. doi: 10.1093/brain/awy117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awy117</ArticleId><ArticleId IdType="pmc">PMC6022692</ArticleId><ArticleId IdType="pubmed">29733334</ArticleId></ArticleIdList></Reference><Reference><Citation>Tai C, et al. Tau reduction prevents key features of autism in mouse models. Neuron. 2020;106(3):421&#x2013;437. doi: 10.1016/j.neuron.2020.01.038.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2020.01.038</ArticleId><ArticleId IdType="pmc">PMC7210056</ArticleId><ArticleId IdType="pubmed">32126198</ArticleId></ArticleIdList></Reference><Reference><Citation>Roberson ED, et al. Reducing endogenous tau ameliorates amyloid beta-induced deficits in an Alzheimer&#x2019;s disease mouse model. Science. 2007;316(5825):750&#x2013;754. doi: 10.1126/science.1141736.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1141736</ArticleId><ArticleId IdType="pubmed">17478722</ArticleId></ArticleIdList></Reference><Reference><Citation>DeVos SL, et al. Tau reduction prevents neuronal loss and reverses pathological tau deposition and seeding in mice with tauopathy. Sci Transl Med. 2017;9(374):eaag0481. doi: 10.1126/scitranslmed.aag0481.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.aag0481</ArticleId><ArticleId IdType="pmc">PMC5792300</ArticleId><ArticleId IdType="pubmed">28123067</ArticleId></ArticleIdList></Reference><Reference><Citation>Petrozziello T, et al. Targeting tau mitigates mitochondrial fragmentation and oxidative stress in amyotrophic lateral sclerosis. Mol Neurobiol. 2022;59(1):683&#x2013;702. doi: 10.1007/s12035-021-02557-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-021-02557-w</ArticleId><ArticleId IdType="pubmed">34757590</ArticleId></ArticleIdList></Reference><Reference><Citation>Jabbari E, Duff KE. Tau-targeting antibody therapies: too late, wrong epitope or wrong target? Nat Med. 2021;27(8):1341&#x2013;1342. doi: 10.1038/s41591-021-01465-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01465-9</ArticleId><ArticleId IdType="pubmed">34385709</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen JL, et al. Design, optimization, and study of small molecules that target tau pre-mRNA and affect splicing. J Am Chem Soc. 2020;142(19):8706&#x2013;8727. doi: 10.1021/jacs.0c00768.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/jacs.0c00768</ArticleId><ArticleId IdType="pmc">PMC7357857</ArticleId><ArticleId IdType="pubmed">32364710</ArticleId></ArticleIdList></Reference><Reference><Citation>Schoch KM, et al. Increased 4R-tau induces pathological changes in a human-tau mouse model. Neuron. 2016;90(5):941&#x2013;947. doi: 10.1016/j.neuron.2016.04.042.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2016.04.042</ArticleId><ArticleId IdType="pmc">PMC5040069</ArticleId><ArticleId IdType="pubmed">27210553</ArticleId></ArticleIdList></Reference><Reference><Citation>Esp&#xed;ndola SL, et al. Modulation of tau isoforms imbalance precludes tau pathology and cognitive decline in a mouse model of tauopathy. Cell Rep. 2018;23(3):709&#x2013;715. doi: 10.1016/j.celrep.2018.03.079.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2018.03.079</ArticleId><ArticleId IdType="pubmed">29669277</ArticleId></ArticleIdList></Reference><Reference><Citation>Wegmann S, et al. Persistent repression of tau in the brain using engineered zinc finger protein transcription factors. Sci Adv. 2021;7(12):eabe1611. doi: 10.1126/sciadv.abe1611.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.abe1611</ArticleId><ArticleId IdType="pmc">PMC7978433</ArticleId><ArticleId IdType="pubmed">33741591</ArticleId></ArticleIdList></Reference><Reference><Citation>Simone R, et al. MIR-NATs repress MAPT translation and aid proteostasis in neurodegeneration. Nature. 2021;594(7861):117&#x2013;123. doi: 10.1038/s41586-021-03556-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03556-6</ArticleId><ArticleId IdType="pmc">PMC7610982</ArticleId><ArticleId IdType="pubmed">34012113</ArticleId></ArticleIdList></Reference><Reference><Citation>Heller GT, et al. Targeting disordered proteins with small molecules using entropy. Trends Biochem Sci. 2015;40(9):491&#x2013;496. doi: 10.1016/j.tibs.2015.07.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tibs.2015.07.004</ArticleId><ArticleId IdType="pubmed">26275458</ArticleId></ArticleIdList></Reference><Reference><Citation>Francois-Moutal L, et al. Direct targeting of TDP-43, from small molecules to biologics: the therapeutic landscape. RSC Chem Biol. 2021;2(4):1158&#x2013;1166. doi: 10.1039/D1CB00110H.</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/D1CB00110H</ArticleId><ArticleId IdType="pmc">PMC8341936</ArticleId><ArticleId IdType="pubmed">34458829</ArticleId></ArticleIdList></Reference><Reference><Citation>Pickhardt M, et al. Identification of small molecule inhibitors of tau aggregation by targeting monomeric tau as a potential therapeutic approach for tauopathies. Curr Alzheimer Res. 2015;12(9):814&#x2013;828. doi: 10.2174/156720501209151019104951.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/156720501209151019104951</ArticleId><ArticleId IdType="pmc">PMC4976804</ArticleId><ArticleId IdType="pubmed">26510979</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L, et al. Small molecule therapeutics for tauopathy in Alzheimer&#x2019;s disease: walking on the path of most resistance. Eur J Med Chem. 2021;209:112915. doi: 10.1016/j.ejmech.2020.112915.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejmech.2020.112915</ArticleId><ArticleId IdType="pubmed">33139110</ArticleId></ArticleIdList></Reference><Reference><Citation>Baggett DW, Nath A. The rational discovery of a tau aggregation inhibitor. Biochemistry. 2018;57(42):6099&#x2013;6107. doi: 10.1021/acs.biochem.8b00581.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.biochem.8b00581</ArticleId><ArticleId IdType="pmc">PMC7021323</ArticleId><ArticleId IdType="pubmed">30247897</ArticleId></ArticleIdList></Reference><Reference><Citation>Mirbaha H, et al. Inert and seed-competent tau monomers suggest structural origins of aggregation. Elife. 2018;7:e36584. doi: 10.7554/eLife.36584.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.36584</ArticleId><ArticleId IdType="pmc">PMC6039173</ArticleId><ArticleId IdType="pubmed">29988016</ArticleId></ArticleIdList></Reference><Reference><Citation>Taniguchi S, et al. Inhibition of heparin-induced tau filament formation by phenothiazines, polyphenols, and porphyrins. J Biol Chem. 2005;280(9):7614&#x2013;7623. doi: 10.1074/jbc.M408714200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M408714200</ArticleId><ArticleId IdType="pubmed">15611092</ArticleId></ArticleIdList></Reference><Reference><Citation>Akoury E, et al. Mechanistic basis of phenothiazine-driven inhibition of tau aggregation. Angew Chem Int Ed Engl. 2013;52(12):3511&#x2013;3515. doi: 10.1002/anie.201208290.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/anie.201208290</ArticleId><ArticleId IdType="pubmed">23401175</ArticleId></ArticleIdList></Reference><Reference><Citation>Schafer KN, et al. Structural determinants of tau aggregation inhibitor potency. J Biol Chem. 2013;288(45):32599&#x2013;32611. doi: 10.1074/jbc.M113.503474.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M113.503474</ArticleId><ArticleId IdType="pmc">PMC3820892</ArticleId><ArticleId IdType="pubmed">24072703</ArticleId></ArticleIdList></Reference><Reference><Citation>Mollasalehi N, et al. An allosteric modulator of RNA binding targeting the N-terminal domain of TDP-43 yields neuroprotective properties. ACS Chem Biol. 2020;15(11):2854&#x2013;2859. doi: 10.1021/acschembio.0c00494.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acschembio.0c00494</ArticleId><ArticleId IdType="pmc">PMC8548910</ArticleId><ArticleId IdType="pubmed">33044808</ArticleId></ArticleIdList></Reference><Reference><Citation>Abskharon R, et al. Cryo-EM structure of RNA-induced tau fibrils reveals a small C-terminal core that may nucleate fibril formation. Proc Natl Acad Sci U S A. 2022;119(15):e2119952119. doi: 10.1073/pnas.2119952119.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2119952119</ArticleId><ArticleId IdType="pmc">PMC9169762</ArticleId><ArticleId IdType="pubmed">35377792</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang H, et al. RNA controls PolyQ protein phase transitions. Mol Cell. 2015;60(2):220&#x2013;230. doi: 10.1016/j.molcel.2015.09.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2015.09.017</ArticleId><ArticleId IdType="pmc">PMC5221516</ArticleId><ArticleId IdType="pubmed">26474065</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhardwaj A, et al. Characterizing TDP-43 interaction with its RNA targets. Nucleic Acids Res. 2013;41(9):5062&#x2013;5074. doi: 10.1093/nar/gkt189.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkt189</ArticleId><ArticleId IdType="pmc">PMC3643599</ArticleId><ArticleId IdType="pubmed">23519609</ArticleId></ArticleIdList></Reference><Reference><Citation>Pozzi S, et al. Virus-mediated delivery of antibody targeting TAR DNA-binding protein-43 mitigates associated neuropathology. J Clin Invest. 2019;129(4):1581&#x2013;1595. doi: 10.1172/JCI123931.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI123931</ArticleId><ArticleId IdType="pmc">PMC6436898</ArticleId><ArticleId IdType="pubmed">30667370</ArticleId></ArticleIdList></Reference><Reference><Citation>Abskharon R, et al. Crystal structure of a conformational antibody that binds tau oligomers and inhibits pathological seeding by extracts from donors with Alzheimer&#x2019;s disease. J Biol Chem. 2020;295(31):10662&#x2013;10676. doi: 10.1074/jbc.RA120.013638.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.RA120.013638</ArticleId><ArticleId IdType="pmc">PMC7397112</ArticleId><ArticleId IdType="pubmed">32493775</ArticleId></ArticleIdList></Reference><Reference><Citation>Jicha GA, et al. Alz-50 and MC-1, a new monoclonal antibody raised to paired helical filaments, recognize conformational epitopes on recombinant tau. J Neurosci Res. 1997;48(2):128&#x2013;132. doi: 10.1002/(SICI)1097-4547(19970415)48:2&lt;128::AID-JNR5&gt;3.0.CO;2-E.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/(SICI)1097-4547(19970415)48:2&lt;128::AID-JNR5&gt;3.0.CO;2-E</ArticleId><ArticleId IdType="pubmed">9130141</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakamura K, et al. Proline isomer-specific antibodies reveal the early pathogenic tau conformation in Alzheimer&#x2019;s disease. Cell. 2012;149(1):232&#x2013;244. doi: 10.1016/j.cell.2012.02.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2012.02.016</ArticleId><ArticleId IdType="pmc">PMC3601591</ArticleId><ArticleId IdType="pubmed">22464332</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu KP et al. Potential of the antibody against cis-phosphorylated tau in the early diagnosis, treatment, and prevention of Alzheimer disease and brain injury. JAMA Neurol. 2016;73(11):1356&#x2013;1362. doi: 10.1001/jamaneurol.2016.2027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2016.2027</ArticleId><ArticleId IdType="pubmed">27654282</ArticleId></ArticleIdList></Reference><Reference><Citation>Qiu C, et al. Cis P-tau underlies vascular contribution to cognitive impairment and dementia and can be effectively targeted by immunotherapy in mice. Sci Transl Med. 2021;13(596):eaaz7615. doi: 10.1126/scitranslmed.aaz7615.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.aaz7615</ArticleId><ArticleId IdType="pmc">PMC8272885</ArticleId><ArticleId IdType="pubmed">34078745</ArticleId></ArticleIdList></Reference><Reference><Citation>Kondo A, et al. Antibody against early driver of neurodegeneration cis P-tau blocks brain injury and tauopathy. Nature. 2015;523(7561):431&#x2013;436. doi: 10.1038/nature14658.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature14658</ArticleId><ArticleId IdType="pmc">PMC4718588</ArticleId><ArticleId IdType="pubmed">26176913</ArticleId></ArticleIdList></Reference><Reference><Citation>Albayram O, et al. Cis P-tau is induced in clinical and preclinical brain injury and contributes to post-injury sequelae. Nat Commun. 2017;8(1):1000. doi: 10.1038/s41467-017-01068-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-017-01068-4</ArticleId><ArticleId IdType="pmc">PMC5645414</ArticleId><ArticleId IdType="pubmed">29042562</ArticleId></ArticleIdList></Reference><Reference><Citation>Porta S, et al. Patient-derived frontotemporal lobar degeneration brain extracts induce formation and spreading of TDP-43 pathology in vivo. Nat Commun. 2018;9(1):4220. doi: 10.1038/s41467-018-06548-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-018-06548-9</ArticleId><ArticleId IdType="pmc">PMC6181940</ArticleId><ArticleId IdType="pubmed">30310141</ArticleId></ArticleIdList></Reference><Reference><Citation>Jucker M, Walker LC. Propagation and spread of pathogenic protein assemblies in neurodegenerative diseases. Nat Neurosci. 2018;21(10):1341&#x2013;1349. doi: 10.1038/s41593-018-0238-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-018-0238-6</ArticleId><ArticleId IdType="pmc">PMC6375686</ArticleId><ArticleId IdType="pubmed">30258241</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaquer-Alicea J, et al. Tau strains shape disease. Acta Neuropathol. 2021;142(1):57&#x2013;71. doi: 10.1007/s00401-021-02301-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-021-02301-7</ArticleId><ArticleId IdType="pmc">PMC8217038</ArticleId><ArticleId IdType="pubmed">33830330</ArticleId></ArticleIdList></Reference><Reference><Citation>Koehler LC, et al. TDP-43 oligomerization and phase separation properties are necessary for autoregulation. Front Neurosci. 2022;16:818655. doi: 10.3389/fnins.2022.818655.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2022.818655</ArticleId><ArticleId IdType="pmc">PMC9048411</ArticleId><ArticleId IdType="pubmed">35495061</ArticleId></ArticleIdList></Reference><Reference><Citation>Wagner J, et al. Anle138b: a novel oligomer modulator for disease-modifying therapy of neurodegenerative diseases such as prion and Parkinson&#x2019;s disease. Acta Neuropathol. 2013;125(6):795&#x2013;813. doi: 10.1007/s00401-013-1114-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-013-1114-9</ArticleId><ArticleId IdType="pmc">PMC3661926</ArticleId><ArticleId IdType="pubmed">23604588</ArticleId></ArticleIdList></Reference><Reference><Citation>Ingham DJ, et al. Fungally derived isoquinoline demonstrates inducer-specific tau aggregation inhibition. Biochemistry. 2021;60(21):1658&#x2013;1669. doi: 10.1021/acs.biochem.1c00111.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.biochem.1c00111</ArticleId><ArticleId IdType="pmc">PMC8173610</ArticleId><ArticleId IdType="pubmed">34009955</ArticleId></ArticleIdList></Reference><Reference><Citation>Baggett DW, Nath A. Structure-activity relationships of novel tau ligands: passive fibril binders and active aggregation inhibitors. ACS Chem Biol. 2022;17(3):701&#x2013;708. doi: 10.1021/acschembio.2c00012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acschembio.2c00012</ArticleId><ArticleId IdType="pmc">PMC9381419</ArticleId><ArticleId IdType="pubmed">35147406</ArticleId></ArticleIdList></Reference><Reference><Citation>Wagner J, et al. Reducing tau aggregates with anle138b delays disease progression in a mouse model of tauopathies. Acta Neuropathol. 2015;130(5):619&#x2013;631. doi: 10.1007/s00401-015-1483-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-015-1483-3</ArticleId><ArticleId IdType="pmc">PMC4612332</ArticleId><ArticleId IdType="pubmed">26439832</ArticleId></ArticleIdList></Reference><Reference><Citation>Seidler PM, et al. Structure-based discovery of small molecules that disaggregate Alzheimer&#x2019;s disease tissue derived tau fibrils in vitro. Nat Commun. 2022;13(1):5451. doi: 10.1038/s41467-022-32951-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-32951-4</ArticleId><ArticleId IdType="pmc">PMC9481533</ArticleId><ArticleId IdType="pubmed">36114178</ArticleId></ArticleIdList></Reference><Reference><Citation>Seidler PM, et al. Structure-based inhibitors of tau aggregation. Nat Chem. 2018;10(2):170&#x2013;176. doi: 10.1038/nchem.2889.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nchem.2889</ArticleId><ArticleId IdType="pmc">PMC5784779</ArticleId><ArticleId IdType="pubmed">29359764</ArticleId></ArticleIdList></Reference><Reference><Citation>Owen I, Shewmaker F. The role of post-translational modifications in the phase transitions of intrinsically disordered proteins. Int J Mol Sci. 2019;20(21):5501. doi: 10.3390/ijms20215501.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms20215501</ArticleId><ArticleId IdType="pmc">PMC6861982</ArticleId><ArticleId IdType="pubmed">31694155</ArticleId></ArticleIdList></Reference><Reference><Citation>Jeon P, et al. Regulation of cellular ribonucleoprotein granules: from assembly to degradation via post-translational modification. Cells. 2022;11(13):2063. doi: 10.3390/cells11132063.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells11132063</ArticleId><ArticleId IdType="pmc">PMC9265587</ArticleId><ArticleId IdType="pubmed">35805146</ArticleId></ArticleIdList></Reference><Reference><Citation>Sternburg EL, et al. Post-translational modifications on RNA-binding proteins: accelerators, brakes, or passengers in neurodegeneration? Trends Biochem Sci. 2022;47(1):6&#x2013;22. doi: 10.1016/j.tibs.2021.07.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tibs.2021.07.004</ArticleId><ArticleId IdType="pubmed">34366183</ArticleId></ArticleIdList></Reference><Reference><Citation>Wesseling H, et al. Tau PTM profiles identify patient heterogeneity and stages of Alzheimer&#x2019;s disease. Cell. 2020;183(6):1699&#x2013;1713. doi: 10.1016/j.cell.2020.10.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.10.029</ArticleId><ArticleId IdType="pmc">PMC8168922</ArticleId><ArticleId IdType="pubmed">33188775</ArticleId></ArticleIdList></Reference><Reference><Citation>Farina S, et al. Post-translational modifications modulate proteinopathies of TDP-43, FUS and hnRNP-A/B in amyotrophic lateral sclerosis. Front Mol Biosci. 2021;8:693325. doi: 10.3389/fmolb.2021.693325.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmolb.2021.693325</ArticleId><ArticleId IdType="pmc">PMC8287968</ArticleId><ArticleId IdType="pubmed">34291086</ArticleId></ArticleIdList></Reference><Reference><Citation>Rahman S. Posttranslational modifications of TDP-43. In: Kumar V, Jaiswal MK, eds. TDP-43 and Neurodegeneration. Elsevier; 2022:45&#x2013;79.</Citation></Reference><Reference><Citation>Gruijs da Silva LA, et al. Disease-linked TDP-43 hyperphosphorylation suppresses TDP-43 condensation and aggregation. EMBO J. 2022;41(8):e108443. doi: 10.15252/embj.2021108443.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.2021108443</ArticleId><ArticleId IdType="pmc">PMC9016352</ArticleId><ArticleId IdType="pubmed">35112738</ArticleId></ArticleIdList></Reference><Reference><Citation>Ukmar-Godec T, et al. Lysine/RNA-interactions drive and regulate biomolecular condensation. Nat Commun. 2019;10(1):2909. doi: 10.1038/s41467-019-10792-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-019-10792-y</ArticleId><ArticleId IdType="pmc">PMC6606616</ArticleId><ArticleId IdType="pubmed">31266957</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen TJ, et al. The acetylation of tau inhibits its function and promotes pathological tau aggregation. Nat Commun. 2011;2:252. doi: 10.1038/ncomms1255.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms1255</ArticleId><ArticleId IdType="pmc">PMC3120096</ArticleId><ArticleId IdType="pubmed">21427723</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu H, et al. HSP70 chaperones RNA-free TDP-43 into anisotropic intranuclear liquid spherical shells. Science. 2021;371(6529):eabb4309. doi: 10.1126/science.abb4309.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abb4309</ArticleId><ArticleId IdType="pmc">PMC8286096</ArticleId><ArticleId IdType="pubmed">33335017</ArticleId></ArticleIdList></Reference><Reference><Citation>Shin MK, et al. Reducing acetylated tau is neuroprotective in brain injury. Cell. 2021;184(10):2715&#x2013;2732. doi: 10.1016/j.cell.2021.03.032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2021.03.032</ArticleId><ArticleId IdType="pmc">PMC8491234</ArticleId><ArticleId IdType="pubmed">33852912</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen TJ, et al. An acetylation switch controls TDP-43 function and aggregation propensity. Nat Commun. 2015;6:5845. doi: 10.1038/ncomms6845.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms6845</ArticleId><ArticleId IdType="pmc">PMC4407365</ArticleId><ArticleId IdType="pubmed">25556531</ArticleId></ArticleIdList></Reference><Reference><Citation>Aikio M, et al. Opposing roles of p38&#x3b1;-mediated phosphorylation and arginine methylation in driving TDP-43 proteinopathy [preprint]. Posted on bioRxiv August 4, 2021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.08.04.455154</ArticleId></ArticleIdList></Reference><Reference><Citation>Stefanoska K, et al. Alzheimer&#x2019;s disease: ablating single master site abolishes tau hyperphosphorylation. Sci Adv. 2022;8(27):eabl8809. doi: 10.1126/sciadv.abl8809.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.abl8809</ArticleId><ArticleId IdType="pmc">PMC9258953</ArticleId><ArticleId IdType="pubmed">35857446</ArticleId></ArticleIdList></Reference><Reference><Citation>Riback JA, et al. Composition-dependent thermodynamics of intracellular phase separation. Nature. 2020;581(7807):209&#x2013;214. doi: 10.1038/s41586-020-2256-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2256-2</ArticleId><ArticleId IdType="pmc">PMC7733533</ArticleId><ArticleId IdType="pubmed">32405004</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang L, et al. Interaction of tau with HNRNPA2B1 and N6-methyladenosine RNA mediates the progression of tauopathy. Mol Cell. 2021;81(20):4209&#x2013;4227. doi: 10.1016/j.molcel.2021.07.038.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2021.07.038</ArticleId><ArticleId IdType="pmc">PMC8541906</ArticleId><ArticleId IdType="pubmed">34453888</ArticleId></ArticleIdList></Reference><Reference><Citation>Wheeler JM, et al. Activity of the poly(A) binding protein MSUT2 determines susceptibility to pathological tau in the mammalian brain. Sci Transl Med. 2019;11(523):eaao6545. doi: 10.1126/scitranslmed.aao6545.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.aao6545</ArticleId><ArticleId IdType="pmc">PMC7311111</ArticleId><ArticleId IdType="pubmed">31852801</ArticleId></ArticleIdList></Reference><Reference><Citation>Apicco DJ, et al. Reducing the RNA binding protein TIA1 protects against tau-mediated neurodegeneration in vivo. Nat Neurosci. 2018;21(1):72&#x2013;80. doi: 10.1038/s41593-017-0022-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-017-0022-z</ArticleId><ArticleId IdType="pmc">PMC5745051</ArticleId><ArticleId IdType="pubmed">29273772</ArticleId></ArticleIdList></Reference><Reference><Citation>Becker LA, et al. Therapeutic reduction of ataxin-2 extends lifespan and reduces pathology in TDP-43 mice. Nature. 2017;544(7650):367&#x2013;371. doi: 10.1038/nature22038.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature22038</ArticleId><ArticleId IdType="pmc">PMC5642042</ArticleId><ArticleId IdType="pubmed">28405022</ArticleId></ArticleIdList></Reference><Reference><Citation>Vanderweyde T, et al. Interaction of tau with the RNA-binding protein TIA1 regulates tau pathophysiology and toxicity. Cell Rep. 2016;15(7):1455&#x2013;1466. doi: 10.1016/j.celrep.2016.04.045.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2016.04.045</ArticleId><ArticleId IdType="pmc">PMC5325702</ArticleId><ArticleId IdType="pubmed">27160897</ArticleId></ArticleIdList></Reference><Reference><Citation>Ash PEA, et al. TIA1 potentiates tau phase separation and promotes generation of toxic oligomeric tau. Proc Natl Acad Sci U S A. 2021;118(9):e2014188118. doi: 10.1073/pnas.2014188118.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2014188118</ArticleId><ArticleId IdType="pmc">PMC7936275</ArticleId><ArticleId IdType="pubmed">33619090</ArticleId></ArticleIdList></Reference><Reference><Citation>Lester E, et al. Tau aggregates are RNA-protein assemblies that mislocalize multiple nuclear speckle components. Neuron. 2021;109(10):1675&#x2013;1691. doi: 10.1016/j.neuron.2021.03.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2021.03.026</ArticleId><ArticleId IdType="pmc">PMC8141031</ArticleId><ArticleId IdType="pubmed">33848474</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuniga G, et al. Tau-induced deficits in nonsense-mediated mRNA decay contribute to neurodegeneration. Alzheimers Dement. 2023;19(2):405&#x2013;420. doi: 10.1002/alz.12653.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/alz.12653</ArticleId><ArticleId IdType="pmc">PMC9673995</ArticleId><ArticleId IdType="pubmed">35416419</ArticleId></ArticleIdList></Reference><Reference><Citation>Elden AC, et al. Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS. Nature. 2010;466(7310):1069&#x2013;1075. doi: 10.1038/nature09320.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature09320</ArticleId><ArticleId IdType="pmc">PMC2965417</ArticleId><ArticleId IdType="pubmed">20740007</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang K, et al. The C9orf72 repeat expansion disrupts nucleocytoplasmic transport. Nature. 2015;525(7567):56&#x2013;61. doi: 10.1038/nature14973.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature14973</ArticleId><ArticleId IdType="pmc">PMC4800742</ArticleId><ArticleId IdType="pubmed">26308891</ArticleId></ArticleIdList></Reference><Reference><Citation>Bush JA, et al. Ribonuclease recruitment using a small molecule reduced c9ALS/FTD r(G4C2) repeat expansion in vitro and in vivo ALS models. Sci Transl Med. 2021;13(617):eabd5991. doi: 10.1126/scitranslmed.abd5991.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.abd5991</ArticleId><ArticleId IdType="pmc">PMC9533739</ArticleId><ArticleId IdType="pubmed">34705518</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsukawa K, et al. Long non-coding RNA NEAT1_1 ameliorates TDP-43 toxicity in in vivo models of TDP-43 proteinopathy. RNA Biol. 2021;18(11):1546&#x2013;1554. doi: 10.1080/15476286.2020.1860580.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15476286.2020.1860580</ArticleId><ArticleId IdType="pmc">PMC8583295</ArticleId><ArticleId IdType="pubmed">33427561</ArticleId></ArticleIdList></Reference><Reference><Citation>Chatterjee B, et al. RNA modifications and RNA metabolism in neurological disease pathogenesis. Int J Mol Sci. 2021;22(21):10. doi: 10.3390/ijms222111870.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms222111870</ArticleId><ArticleId IdType="pmc">PMC8584444</ArticleId><ArticleId IdType="pubmed">34769301</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiapaer Z, et al. Regulation and roles of RNA modifications in aging-related diseases. Aging Cell. 2022;21(7):e13657. doi: 10.1111/acel.13657.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/acel.13657</ArticleId><ArticleId IdType="pmc">PMC9282851</ArticleId><ArticleId IdType="pubmed">35718942</ArticleId></ArticleIdList></Reference><Reference><Citation>Roundtree IA, et al. Dynamic RNA modifications in gene expression regulation. Cell. 2017;169(7):1187&#x2013;1200. doi: 10.1016/j.cell.2017.05.045.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2017.05.045</ArticleId><ArticleId IdType="pmc">PMC5657247</ArticleId><ArticleId IdType="pubmed">28622506</ArticleId></ArticleIdList></Reference><Reference><Citation>Drino A, Schaefer MR. RNAs, phase separation, and membrane-less organelles: are post-transcriptional modifications modulating organelle dynamics? Bioessays. 2018;40(12):e1800085. doi: 10.1002/bies.201800085.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/bies.201800085</ArticleId><ArticleId IdType="pubmed">30370622</ArticleId></ArticleIdList></Reference><Reference><Citation>Edupuganti RR, et al. N6-methyladenosine (m6A) recruits and repels proteins to regulate mRNA homeostasis. Nat Struct Mol Biol. 2017;24(10):870&#x2013;878. doi: 10.1038/nsmb.3462.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nsmb.3462</ArticleId><ArticleId IdType="pmc">PMC5725193</ArticleId><ArticleId IdType="pubmed">28869609</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee J-H, et al. Enhancer RNA m6A methylation facilitates transcriptional condensate formation and gene activation. Mol Cell. 2021;81(16):3368&#x2013;3385. doi: 10.1016/j.molcel.2021.07.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2021.07.024</ArticleId><ArticleId IdType="pmc">PMC8383322</ArticleId><ArticleId IdType="pubmed">34375583</ArticleId></ArticleIdList></Reference><Reference><Citation>Zaccara S, et al. Reading, writing and erasing mRNA methylation. Nat Rev Mol Cell Biol. 2019;20(10):608&#x2013;624. doi: 10.1038/s41580-019-0168-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41580-019-0168-5</ArticleId><ArticleId IdType="pubmed">31520073</ArticleId></ArticleIdList></Reference><Reference><Citation>McMillan M, et al. RNA methylation influences TDP43 binding and disease pathogenesis in models of amyotrophic lateral sclerosis and frontotemporal dementia. Mol Cell. 2023;83(2):219&#x2013;236. doi: 10.1016/j.molcel.2022.12.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2022.12.019</ArticleId><ArticleId IdType="pmc">PMC9899051</ArticleId><ArticleId IdType="pubmed">36634675</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaushik S, Cuervo AM. Proteostasis and aging. Nat Med. 2015;21(12):1406&#x2013;1415. doi: 10.1038/nm.4001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.4001</ArticleId><ArticleId IdType="pubmed">26646497</ArticleId></ArticleIdList></Reference><Reference><Citation>Alberti S, Carra S. Quality control of membraneless organelles. J Mol Biol. 2018;430(23):4711&#x2013;4729. doi: 10.1016/j.jmb.2018.05.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmb.2018.05.013</ArticleId><ArticleId IdType="pubmed">29758260</ArticleId></ArticleIdList></Reference><Reference><Citation>Labbadia J, Morimoto RI. The biology of proteostasis in aging and disease. Annu Rev Biochem. 2015;84:435&#x2013;464. doi: 10.1146/annurev-biochem-060614-033955.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-biochem-060614-033955</ArticleId><ArticleId IdType="pmc">PMC4539002</ArticleId><ArticleId IdType="pubmed">25784053</ArticleId></ArticleIdList></Reference><Reference><Citation>Nixon RA. The role of autophagy in neurodegenerative disease. Nat Med. 2013;19(8):983&#x2013;997. doi: 10.1038/nm.3232.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.3232</ArticleId><ArticleId IdType="pubmed">23921753</ArticleId></ArticleIdList></Reference><Reference><Citation>Vargas JNS, et al. The mechanisms and roles of selective autophagy in mammals. Nat Rev Mol Cell Biol. 2023;24(3):167&#x2013;185. doi: 10.1038/s41580-022-00542-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41580-022-00542-2</ArticleId><ArticleId IdType="pubmed">36302887</ArticleId></ArticleIdList></Reference><Reference><Citation>McMillan M, et al. RNA methylation influences TDP43 binding and disease pathogenesis in models of amyotrophic lateral sclerosis and frontotemporal dementia. Mol Cell. 2023;83(2):219&#x2013;236. doi: 10.1016/j.molcel.2022.12.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2022.12.019</ArticleId><ArticleId IdType="pmc">PMC9899051</ArticleId><ArticleId IdType="pubmed">36634675</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamasaki A, et al. Liquidity is a critical determinant for selective autophagy of protein condensates. Mol Cell. 2020;77(6):1163&#x2013;1175. doi: 10.1016/j.molcel.2019.12.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2019.12.026</ArticleId><ArticleId IdType="pubmed">31995729</ArticleId></ArticleIdList></Reference><Reference><Citation>Jinwal UK, et al. Hsp70 ATPase modulators as therapeutics for Alzheimer&#x2019;s and other neurodegenerative diseases. Mol Cell Pharmacol. 2010;2(2):43&#x2013;46.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2879647</ArticleId><ArticleId IdType="pubmed">20523917</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiang AN, et al. Synthesis and evaluation of esterified Hsp70 agonists in cellular models of protein aggregation and folding. Bioorg Med Chem. 2019;27(1):79&#x2013;91. doi: 10.1016/j.bmc.2018.11.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bmc.2018.11.011</ArticleId><ArticleId IdType="pmc">PMC6298824</ArticleId><ArticleId IdType="pubmed">30528127</ArticleId></ArticleIdList></Reference><Reference><Citation>Babu M, et al. Peptidyl prolyl isomerase a modulates the liquid-liquid phase separation of proline-rich IDPs. J Am Chem Soc. 2022;144(35):16157&#x2013;16163. doi: 10.1021/jacs.2c07149.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/jacs.2c07149</ArticleId><ArticleId IdType="pmc">PMC9460772</ArticleId><ArticleId IdType="pubmed">36018855</ArticleId></ArticleIdList></Reference><Reference><Citation>Hutten S, et al. Nuclear import receptors directly bind to arginine-rich dipeptide repeat proteins and suppress their pathological interactions. Cell Rep. 2020;33(12):108538. doi: 10.1016/j.celrep.2020.108538.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2020.108538</ArticleId><ArticleId IdType="pmc">PMC7814465</ArticleId><ArticleId IdType="pubmed">33357437</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo L, et al. Nuclear-import receptors reverse aberrant phase transitions of RNA-binding proteins with prion-like domains. Cell. 2018;173(3):677&#x2013;692. doi: 10.1016/j.cell.2018.03.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2018.03.002</ArticleId><ArticleId IdType="pmc">PMC5911940</ArticleId><ArticleId IdType="pubmed">29677512</ArticleId></ArticleIdList></Reference><Reference><Citation>Caballero B, et al. Interplay of pathogenic forms of human tau with different autophagic pathways. Aging Cell. 2018;17(1):e12692. doi: 10.1111/acel.12692.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/acel.12692</ArticleId><ArticleId IdType="pmc">PMC5770880</ArticleId><ArticleId IdType="pubmed">29024336</ArticleId></ArticleIdList></Reference><Reference><Citation>Carrettiero DC, et al. Stress routes clients to the proteasome via a BAG2 ubiquitin-independent degradation condensate. Nat Commun. 2022;13(1):3074. doi: 10.1038/s41467-022-30751-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-30751-4</ArticleId><ArticleId IdType="pmc">PMC9163039</ArticleId><ArticleId IdType="pubmed">35654899</ArticleId></ArticleIdList></Reference><Reference><Citation>Scotter EL, et al. Differential roles of the ubiquitin proteasome system and autophagy in the clearance of soluble and aggregated TDP-43 species. J Cell Sci. 2014;127(pt 6):1263&#x2013;1278.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3953816</ArticleId><ArticleId IdType="pubmed">24424030</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan Y, et al. X-linked ubiquitin-specific peptidase 11 increases tauopathy vulnerability in women. Cell. 2022;185(21):3913&#x2013;3930. doi: 10.1016/j.cell.2022.09.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2022.09.002</ArticleId><ArticleId IdType="pmc">PMC9588697</ArticleId><ArticleId IdType="pubmed">36198316</ArticleId></ArticleIdList></Reference><Reference><Citation>Schaler AW, et al. PAC1 receptor-mediated clearance of tau in postsynaptic compartments attenuates tau pathology in mouse brain. Sci Transl Med. 2021;13(595):eaba7394. doi: 10.1126/scitranslmed.aba7394.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.aba7394</ArticleId><ArticleId IdType="pmc">PMC8988215</ArticleId><ArticleId IdType="pubmed">34039738</ArticleId></ArticleIdList></Reference><Reference><Citation>Bourdenx M, et al. Chaperone-mediated autophagy prevents collapse of the neuronal metastable proteome. Cell. 2021;184(10):2696&#x2013;2714. doi: 10.1016/j.cell.2021.03.048.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2021.03.048</ArticleId><ArticleId IdType="pmc">PMC8152331</ArticleId><ArticleId IdType="pubmed">33891876</ArticleId></ArticleIdList></Reference><Reference><Citation>Caballero B, et al. Acetylated tau inhibits chaperone-mediated autophagy and promotes tau pathology propagation in mice. Nat Commun. 2021;12(1):2238. doi: 10.1038/s41467-021-22501-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-22501-9</ArticleId><ArticleId IdType="pmc">PMC8047017</ArticleId><ArticleId IdType="pubmed">33854069</ArticleId></ArticleIdList></Reference><Reference><Citation>Babinchak WM, et al. Small molecules as potent biphasic modulators of protein liquid-liquid phase separation. Nat Commun. 2020;11(1):5574. doi: 10.1038/s41467-020-19211-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-19211-z</ArticleId><ArticleId IdType="pmc">PMC7643064</ArticleId><ArticleId IdType="pubmed">33149109</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang MY, et al. Small-molecule modulation of TDP-43 recruitment to stress granules prevents persistent TDP-43 accumulation in ALS/FTD. Neuron. 2019;103(5):802&#x2013;819. doi: 10.1016/j.neuron.2019.05.048.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2019.05.048</ArticleId><ArticleId IdType="pmc">PMC6728177</ArticleId><ArticleId IdType="pubmed">31272829</ArticleId></ArticleIdList></Reference><Reference><Citation>Kilgore HR, Young RA. Learning the chemical grammar of biomolecular condensates. Nat Chem Biol. 2022;18(12):1298&#x2013;1306. doi: 10.1038/s41589-022-01046-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41589-022-01046-y</ArticleId><ArticleId IdType="pmc">PMC9691472</ArticleId><ArticleId IdType="pubmed">35761089</ArticleId></ArticleIdList></Reference><Reference><Citation>Jonchhe S, et al. Small molecules modulate liquid-to-solid transitions in phase-separated tau condensates. Angew Chem Int Ed. 2022;61(23):e202113156. doi: 10.1002/anie.202113156.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/anie.202113156</ArticleId><ArticleId IdType="pmc">PMC9156559</ArticleId><ArticleId IdType="pubmed">35320624</ArticleId></ArticleIdList></Reference><Reference><Citation>Dai B, et al. Myricetin slows liquid-liquid phase separation of tau and activates ATG5-dependent autophagy to suppress tau toxicity. J Biol Chem. 2021;297(4):101222. doi: 10.1016/j.jbc.2021.101222.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbc.2021.101222</ArticleId><ArticleId IdType="pmc">PMC8551527</ArticleId><ArticleId IdType="pubmed">34560101</ArticleId></ArticleIdList></Reference><Reference><Citation>Gray MJ, et al. Polyphosphate is a primordial chaperone. Mol Cell. 2014;53(5):689&#x2013;699. doi: 10.1016/j.molcel.2014.01.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2014.01.012</ArticleId><ArticleId IdType="pmc">PMC3996911</ArticleId><ArticleId IdType="pubmed">24560923</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel A, et al. ATP as a biological hydrotrope. Science. 2017;356(6339):753&#x2013;756. doi: 10.1126/science.aaf6846.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aaf6846</ArticleId><ArticleId IdType="pubmed">28522535</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang JZ, et al. Phase separation of a PKA regulatory subunit controls cAMP compartmentation and oncogenic signaling. Cell. 2020;182(6):1531&#x2013;1544. doi: 10.1016/j.cell.2020.07.043.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.07.043</ArticleId><ArticleId IdType="pmc">PMC7502557</ArticleId><ArticleId IdType="pubmed">32846158</ArticleId></ArticleIdList></Reference><Reference><Citation>Peinado JR, et al. Sequestration of TDP-43216-414 aggregates by cytoplasmic expression of the proSAAS chaperone. ACS Chem Neurosci. 2022;13(11):1651&#x2013;1665. doi: 10.1021/acschemneuro.2c00156.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acschemneuro.2c00156</ArticleId><ArticleId IdType="pmc">PMC9731516</ArticleId><ArticleId IdType="pubmed">35549000</ArticleId></ArticleIdList></Reference><Reference><Citation>Alberti S, Hyman AA. Are aberrant phase transitions a driver of cellular aging? Bioessays. 2016;38(10):959&#x2013;968. doi: 10.1002/bies.201600042.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/bies.201600042</ArticleId><ArticleId IdType="pmc">PMC5108435</ArticleId><ArticleId IdType="pubmed">27554449</ArticleId></ArticleIdList></Reference><Reference><Citation>Lashuel HA. Rethinking protein aggregation and drug discovery in neurodegenerative diseases: why we need to embrace complexity? Curr Opin Chem Biol. 2021;64:67&#x2013;75. doi: 10.1016/j.cbpa.2021.05.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cbpa.2021.05.006</ArticleId><ArticleId IdType="pubmed">34174698</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen S, et al. Wolframin is a novel regulator of tau pathology and neurodegeneration. Acta Neuropathol. 2022;143(5):547&#x2013;569. doi: 10.1007/s00401-022-02417-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-022-02417-4</ArticleId><ArticleId IdType="pubmed">35389045</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>